Weekly Low‐Dose Versus Three‐Weekly High‐Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non‐Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta‐Analysis of Aggregate Data

BACKGROUND. Three‐weekly high‐dose cisplatin (100 mg/m(2)) is considered the standard systemic regimen given concurrently with postoperative or definitive radiotherapy in locally advanced squamous cell carcinoma of the head and neck (LA‐SCCHN). However, due to unsatisfactory patient tolerance, vario...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Szturz, Petr, Wouters, Kristien, Kiyota, Naomi, Tahara, Makoto, Prabhash, Kumar, Noronha, Vanita, Castro, Ana, Licitra, Lisa, Adelstein, David, Vermorken, Jan B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AlphaMed Press 2017
Aiheet:
Head and Neck Cancers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599190/
https://ncbi.nlm.nih.gov/pubmed/28533474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0015
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia